C. Mcginn

发表

Determination of ventilatory liver movement via radiographic evaluation of diaphragm position.

K. Brock, J. Balter, R. T. Ten Haken, 2001, International journal of radiation oncology, biology, physics.

Improvement of CT-based treatment-planning models of abdominal targets using static exhale imaging.

K. Lam, J. Balter, R. T. Ten Haken, 1998, International journal of radiation oncology, biology, physics.

Daily targeting of intrahepatic tumors for radiotherapy.

James M Balter, Daniel L McShan, Kristy K Brock, 2002, International journal of radiation oncology, biology, physics.

Analysis of radiation-induced liver disease using the Lyman NTCP model.

Daniel Normolle, Randall K Ten Haken, James M Balter, 2002, International journal of radiation oncology, biology, physics.

Response of extraabdominal desmoid tumors to therapy with imatinib mesylate

V. Sondak, Dafydd G. Thomas, C. Mcginn, 2002, Cancer.

A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma

P. Philip, M. Talamonti, C. Mcginn, 2006, Annals of Surgical Oncology.

The mechanism of action of radiosensitization of conventional chemotherapeutic agents.

C. Mcginn, T. Lawrence, A. W. Blackstock, 2003, Seminars in radiation oncology.

Recent advances in the use of radiosensitizing nucleosides.

C. Mcginn, T. Lawrence, 2001, Seminars in radiation oncology.

Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long‐term effects

P. Barnes, C. Mcginn, J. Loeffler, 1990, Cancer.

Radiosensitization by gemcitabine.

C. Mcginn, T. Lawrence, A. Eisbruch, 1999, Oncology.

NCCN Practice Guidelines for Colorectal Cancer.

M. Choti, T. Yeatman, N. Petrelli, 2000, Oncology.

Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.

A. Chang, C. Mcginn, T. Lawrence, 2005, International journal of radiation oncology, biology, physics.

A Phase II Study of Preoperative Capecitabine and Radiation Therapy in Patients With Rectal Cancer

K. Griffith, P. Philip, C. Mcginn, 2007, American journal of clinical oncology.

Conformal chemoradiation for primary and metastatic liver malignancies.

L. Dawson, C. Mcginn, T. Lawrence, 2003, Seminars in surgical oncology.

Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: from the laboratory to the clinic.

C. Mcginn, T. Lawrence, Mary A Davis, 2002, International journal of radiation oncology, biology, physics.

A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers.

A. Drilon, H. Sugita, C. Sima, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiosensitizing nucleosides.

C. Mcginn, T. Lawrence, D. Shewach, 1996, Journal of the National Cancer Institute.

On the development of gemcitabine‐based chemoradiotherapy regimens in pancreatic cancer

C. Mcginn, T. Lawrence, M. Zalupski, 2002, Cancer.

Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration.

Fumito Ito, A. Chang, C. Mcginn, 2003, Cancer research.

Intratumoral Dendritic Cell Administration Radiotherapy Potentiates the Therapeutic Efficacy of Updated

Fumito Ito, A. Chang, C. Mcginn, 2003 .

Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS report no. 6.

C. A. Aguilera, Z. Zakov, W. Green, 1998, American journal of ophthalmology.

Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas

C. Mcginn, T. Lawrence, J. Greenson, 2003, Journal of Gastrointestinal Surgery.

Evolving considerations in the design and interpretation of phase I trials investigating gemcitabine based chemoradiotherapy regimens.

C. Mcginn, 2002, Cancer journal.

The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.

M. Lindstrom, P. Johnston, C. Mcginn, 1994, International journal of radiation oncology, biology, physics.

NCCN practice guidelines for pancreatic cancer.

J. Cameron, A. Benson, C. Willet, 1997, Oncology.

Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.

C. Mcginn, J. Robertson, T. Lawrence, 2004, International journal of radiation oncology, biology, physics.

The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation.

C. Mcginn, T. Kinsella, 1992, Seminars in oncology.

Analysis of radiation-induced gastric and duodenal bleeds using the Lyman-Kutcher-Burman model

L. Dawson, C. Mcginn, T. Lawrence, 2003 .

Cutaneous angiosarcoma of the scalp

V. Sondak, T. Pawlik, C. Mcginn, 2003, Cancer.

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10.

Jennifer I. Lim, C. A. Aguilera, T. A. Rice, 1998, American journal of ophthalmology.

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled. COMS report no. 9.

Jennifer I. Lim, C. A. Aguilera, T. A. Rice, 1998, American journal of ophthalmology.

The clinical rationale for S-phase radiosensitization in human tumors.

C. Mcginn, T. Kinsella, T. J. Kinsella, 1993, Current problems in cancer.

Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.

M. Lindstrom, G. Wilding, C. Mcginn, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.

M. Mehta, B. Badie, G. Wilding, 2004, International journal of radiation oncology, biology, physics.

A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.

M. Kessler, C. Mcginn, J. Robertson, 1997, International journal of radiation oncology, biology, physics.

CONFORMAL RADIATION THERAPY FOR PATIENTS WITH PRIMARY HEPATOBILIARY CANCERS OR COLORECTAL LIVER METASTASES

M. Kessler, C. Mcginn, J. Robertson, 1997 .

Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience

C. Mcginn, J. Robertson, M. Mulcahy, 2016, Journal of Gastrointestinal Cancer.

The role of radiation therapy in resectable retroperitoneal sarcomas.

C. Mcginn, 2000, Surgical oncology.

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

M. Strawderman, D. Smith, C. Mcginn, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies.

R. T. Ten Haken, L. Dawson, C. Mcginn, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model.

R. T. Ten Haken, C. Mcginn, T. Lawrence, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.

J. Berlin, P. Philip, A. Benson, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma.

V. Sondak, K. Griffith, James D. Murphy, 2007, International journal of radiation oncology, biology, physics.

The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy.

R K Ten Haken, J Balter, T S Lawrence, 2001, International journal of radiation oncology, biology, physics.

Dose intensification in curative head and neck cancer radiotherapy--linear quadratic analysis and preliminary assessment of clinical results.

P M Harari, J F Fowler, J. Fowler, 1993, International journal of radiation oncology, biology, physics.

Escalated F ocal L iver R adiation a nd C oncurrent Hepatic A rtery F luorodeoxyuridi ne f or U nresectable Intrahepatic M alignancies

L. Dawson, C. Mcginn, T. Lawrence, 2000 .

Radiation therapy with once-weekly gemcitabine in pancreatic cancer: current status of clinical trials.

C. Mcginn, M. Zalupski, 2003, International journal of radiation oncology, biology, physics.

Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer.

Daniel Normolle, Theodore Lawrence, C. Mcginn, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.

V. Sondak, C. Mcginn, F. Worden, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

70 A phase trial of chemoembolization with mitomycin C following hepatic arterial fluorodeoxyuridine/leucovorin and whole liver radiotherapy for patients with intrahepatic malignancies

C. Mcginn, J. Robertson, T. Lawrence, 1997 .

1041 Leucovorin (LV) modulation of iododeoxyuridine (IdUrd) radiosensitization; A phase I study

C. Mcginn, K. Kunugi, T. Kinsella, 1995 .

Clinical Results of the Combination of Radiation and Fluoropyrimidines in the Treatment of Intrahepatic Cancer.

C. Mcginn, T. Lawrence, Lawrence, 1997, Seminars in radiation oncology.

Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.

C. A. Aguilera, J. Earle, H. Grossniklaus, 2001, Ophthalmology.

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17.

C. A. Aguilera, T. A. Rice, J. Earle, 2001, Archives of ophthalmology.

Erratum: Analysis of radiation-induced liver disease using the Lyman NTCP model (International Journal of Radiation Oncology Biology Physics (2002) 53 (810-821))

J. Balter, L. Dawson, C. Mcginn, 2002 .